Form 483

Delpharm Boucherville Canada Inc. Form 483, 2024-01-26

FDA issued a Form 483 to Delpharm Boucherville Canada Inc. on 2024-01-26 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Delpharm Boucherville Canada Inc. · Boucherville, Canada · Issued January 26, 2024

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Jan 2024
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Edmund F Mrak

26 Jan 2024
21 CFR 211.42(c)

Defined areas of adequate size for operations

Cited by Edmund F Mrak

26 Jan 2024
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Edmund F Mrak

26 Jan 2024
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Edmund F Mrak

Inspected site

DBDelpharm Boucherville Canada Inc.Boucherville, Canada

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere